Naproxen Improves Immune Response to Cancer in People With Lynch Syndrome
Elisa Becze BA, ELS, Editor
Voice
Description
The nonsteroidal anti-inflammatory agent naproxen triggers immune cells in the intestinal lining to fight colorectal cancer in people with Lynch syndrome, researchers reported in Gut.